GEN Exclusives

More »

GEN News Highlights

More »
May 16, 2013

Quest Acquires Concentra’s Toxicology, Clinical Lab Business

  • Quest Diagnostics today said it has acquired the toxicology and clinical laboratory business of Humana subsidiary Concentra. Further, Quest has agreed to be Concentra’s primary provider of workplace drug toxicology and clinical lab testing. Financial terms were not disclosed.

    "With this transaction, Concentra's patients, physicians, and employer clients will gain access to Quest's industry-leading menu of innovative workplace drug and clinical lab diagnostic information services," Steve Rusckowski, Quest president and CEO, said in a statement.

    Under the terms of the agreements, Quest has acquired the assets of Concentra's Memphis, TN-based Advanced Toxicology Network (ATN) lab business, and will provide Concentra and its employer clients and clinical laboratory testing services to patients and physicians in Concentra's network of primary care and urgent care facilities.

    Quest added that the ATN business will be transitioned into its national lab network by the end of this year.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »